Top Core and Group Health Stories
An old idea to lower drug prices sees new life
By Jack CraverSome insurers are embracing the decades-old "quality-adjusted life year" method in drug price negotiations.
News, insight, and analysis from industry experts to help benefits brokers, consultants and advisors make their way through the tumultuous reformed health care marketplace. Content will help them grow their practices by focusing on a wide range of products, discussing new sales and marketing strategies and highlighting innovative and disruptive brokers who are forging a new path in today's benefits marketplace.
Some insurers are embracing the decades-old "quality-adjusted life year" method in drug price negotiations.